Tag Archive for: Pharma

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

/in

Recommendation based on NEXUS data; Minoryx and Neuraxpharm expect European Commission approval by the end of this quarter Barcelona, Spain and Düsseldorf, Germany – 24 July, 2026 – Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation approval under exceptional […]

Read more

New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles

/in

Report outlines 17 targeted actions to address structural barriers hindering leadership progression Copenhagen / Oslo / Stockholm, April 17, 2026 — The Nordic life science sector is losing highly qualified female talent in top leadership positions, according to a new white paper published by Women in Life Science Denmark (WiLD), WiLD Norway, and VILDA Sweden. […]

Read more

Poolbeg Pharma plc – Peer-Reviewed POLB 001 LPS Challenge Trial Paper Published in Frontiers in Immunology

/in

28 January 2026 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces the publication of a peer-reviewed paper from the POLB 001 LPS human challenge trial in Frontiers in Immunology.  Read more…

Read more

Women in Life Science Denmark (WiLD) expands mentoring program to support next generation of female leaders in life sciences

/in

Third cohort of cross-organizational, high-level mentorship program to commence in November 2025 Continued support from the Lundbeck Foundation and the Novo Nordisk Foundation WiLD celebrates its third anniversary with 250+ members in Denmark 28 October 2025, Denmark: Women in Life Science Denmark (WiLD) today announces that it is launching the third cohort of its successful […]

Read more

Optimum Strategic Communications to Host 17th Annual Healthcare Investor Conference

/in

How can companies with promising science secure the capital they need to develop drugs What does pharma need to fill their pipelines as they look to negotiate looming patent cliffs London, UK, 7 October 2025: Optimum Strategic Communications (Optimum), the specialist life sciences communications consultancy, will be hosting its 17th Annual Healthcare Investor Conference on Thursday […]

Read more
© Optimum Strategic Communications.